Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 has not moved since its introduction on Jan 3, 2025, with no cosponsors
IntroducedJan 3, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
Written by the Congressional Research Service [2]. 60 words.
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Context
- Committees
- House Energy and Commerce Committee
- Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 1 of 162 bills enacted since 2013
- Text versions
- 1: introduced in house · 97 words
- Subjects
- CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid
- Latest action
- Jan 3, 2025: Referred to the House Committee on Energy and Commerce.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 0
The bill status record lists no related bills.
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]